Actively Recruiting
Effect of ERAS Nursing on Self-reported Outcomes of Patients Undergoing Minimally Invasive Lung Cancer Surgery
Led by The Second Hospital of Shandong University · Updated on 2022-11-16
600
Participants Needed
1
Research Sites
221 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the impact of the Enhanced Recovery After Surgery (ERAS) nursing program on patients undergoing minimally invasive lung cancer surgery. The study compares patient-reported outcomes, hospital stay length, complications, and readmission rates between those receiving ERAS nursing care and those receiving routine nursing care. This is an interventional, randomized trial led by The Second Hospital of Shandong University. Participants are assigned to either the ERAS nursing group or the non-ERAS nursing group. The ERAS nursing program includes patient education before surgery, management of fluids and anesthesia during surgery, encouragement of early movement, careful fluid control, and early feeding after surgery. The non-ERAS group receives standard routine nursing care without the ERAS protocol. During the study, patients will report their outcomes at baseline, daily after surgery, and weekly for up to four weeks after discharge. Researchers will also track hospital length of stay, postoperative cardiopulmonary complications, and readmission rates from admission through one month after discharge. The total participation duration varies according to these follow-up points, allowing thorough monitoring of recovery and complications.
CONDITIONS
Brief Title
Self-reported Outcomes of Patients in ERAS Nursing
Who Can Participate
Eligibility Criteria
You may qualify if you...
- At least 18 years old
- Scheduled for minimally invasive elective lung surgery
- Able to cooperate with study procedures and communications
You will not qualify if you...
- Had pneumonectomy or conversion to open surgery
- In intensive care after surgery
- Unable to cooperate due to language or speech disorders
- Presence of psychiatric conditions limiting cooperation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - From admission for surgery through hospital discharge
Participants receive either ERAS nursing involving education before surgery, fluid and anesthetic management during surgery, and early ambulation and feeding after surgery, or routine non-ERAS nursing care during their minimally invasive lung cancer surgery.
Daily visits after surgery until discharge
Duration - Up to 4 weeks after discharge
Participants complete weekly self-reported outcome assessments for up to 4 weeks after discharge to monitor recovery and complications.
Weekly visits for up to 4 weeks after discharge
Trial Site Locations
Total: 1 location
1
The second hospital of shandong university
Jinan, Shandong, China, 250033
Actively Recruiting
Research Team
Y
ying liu
H
Hongju Wang
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here